Fortress Biotech - Stock Price History | FBIO

Historical daily share price chart and data for Fortress Biotech since 2021 adjusted for splits. The latest closing stock price for Fortress Biotech as of September 27, 2021 is 3.54.
  • The all-time high Fortress Biotech stock closing price was 12.00 on April 23, 2013.
  • The Fortress Biotech 52-week high stock price is 6.10, which is 72.3% above the current share price.
  • The Fortress Biotech 52-week low stock price is 2.12, which is 40.1% below the current share price.
  • The average Fortress Biotech stock price for the last 52 weeks is 3.48.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Fortress Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.7481 2.7100 4.7800 1.1400 3.1700 23.35%
2019 1.6846 1.0900 2.5700 0.9423 2.5700 198.84%
2018 2.7976 4.0700 5.3500 0.5654 0.8600 -78.45%
2017 3.8383 2.8000 4.9800 2.2500 3.9900 47.78%
2016 2.8123 2.7700 4.1500 1.9500 2.7000 -3.23%
2015 3.0287 2.4000 4.4400 2.0899 2.7900 14.34%
2014 2.0171 2.9100 3.1700 1.4800 2.4400 -7.22%
2013 7.0053 4.8400 12.0000 1.2700 2.6300 -41.69%
2012 6.1311 6.1000 9.5200 4.3600 4.5100 -30.62%
2011 7.8327 11.0000 11.0000 6.0000 6.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.358B $0.046B
Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29